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ABSTRACT
Background/Objective: In recent years, several slightly younger
cohorts have been established in order to study the preclinical and
prodromal phases of dementia. The Consortium to Establish a
Registry for Alzheimer’s Disease (CERAD) wordlist memory test (WLT)
is widely used in dementia research. However, culturally adapted and
demographically adjusted test norms for younger ages are lacking.
Method: This paper investigates effects of age, gender and years
of education on test performance and offers demographically
adjusted norms for the CERAD WLT using a regression-based
norming procedure for the age span 40–80 years based on
healthy controls (n¼ 227) from the Norwegian “Dementia Disease
Initiation” (DDI) (n¼ 168) and “Trønderbrain” (n¼ 59) cohorts. In
order to evaluate normative performance, we apply the norms to
an independent sample of persons diagnosed with mild cognitive
impairment (MCI = 168) and perform multiple regression analyses
to evaluate adjustment of pertinent demographics.
Results: CERAD WLT norms adjusted for effects of age, gender
and educational level are proposed. The norms successfully
adjusted for effects of age, gender and education in an
independent sample of Norwegians with MCI.
Conclusion: Demographically adjusted norms for the CERAD WLT
for ages 40–80 years based on a Norwegian sample are proposed.
To our knowledge, this is the first normative study of this test to
offer demographically adjusted norms for this age span.
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The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD) was founded
to standardize procedures for the evaluation and diagnosis of patients with
Alzheimer’s Disease (AD) (Morris et al., 1989). The instruments developed by CERAD
have been widely used and have been translated into several languages and validated
within different cultural contexts (Fillenbaum et al., 2008). Its clinical utility has mainly
focused on detecting mild cognitive impairment (MCI) and AD with dementia.
Normative data are primarily developed for elderly cohorts (Beeri et al., 2006;
Fillenbaum et al., 2005; Schmidtke & Hermeneit, 2008; Sotaniemi et al., 2012; Welsh
et al., 1994). However, it has been shown that AD develops over 10–15 years before
clinical cognitive impairment is evident (Bateman et al., 2012; Jack et al., 2018). Thus, a
major focus in dementia research has shifted to the asymptomatic or preclinical stages
(Sperling et al., 2011). In order to capture disease events in these stages, several
slightly younger cohorts have been established (Soldan et al., 2013; Weiner et al.,
2015). To capture individual cognitive decline and significant treatment effects at these
stages, more narrow and culturally adapted norms for cognitive tests including CERAD
subtests may need to be established. Recently, Hankee et al. (2016) proposed norms
for the CERAD Word list test (WLT) for younger and middle-aged adults based on an
American sample. These norms are primarily provided for younger persons (<55 years)
and are adjusted for either age or education. However, as learning and memory are
influenced by age, education and gender (Beeri et al., 2006; Liu et al., 2011) correction
for additional demographic factors may be necessary in order to avoid misclassification
of cognitively normal and impaired individuals. In addition, CERAD WLT norms devel-
oped for Scandinavian countries (Danish, Swedish or Norwegian language) are lacking.
The use of discrete norms (e.g. capturing the normative performance of a certain
demographic) requires an adequate sample size in order to ensure that the reference
group is a representative sample of the population distribution. When adjusting for
several demographic characteristics such as gender, age and education, the sample
size requirement increases dramatically (Oosterhuis, van der Ark, & Sijtsma, 2016).
Moreover, norm-based performance may increase substantially by moving from one
age category to the next, due to distinct differences between normative reference
groups (e.g. moving from a 54–59 year group to 60–65 year group) (Zachary &
Gorsuch, 1985). Continuous norms employing regression-based norming procedures
offer a possible solution to these issues by requiring 2.5–5.5 times smaller sample size
(Oosterhuis et al., 2016) while offering the possibility for continuous adjustment of
multiple demographic variables such as age, gender and years of education.
We propose norms adjusted for age, gender and years of education based on a
regression-based norming procedure using the normative performance of healthy con-
trols (n¼ 227) aged 40–80 years from two established prospective Norwegian cohorts,
investigating preclinical and prodromal dementia. A primary utility of these norms is
to detect cognitive decline not caused by normal aging or expected performance dif-
ferences due to gender or educational attainment. Thus, to evaluate the regression-
based norms, we calculate T scores in a group of Norwegian speaking patients
(n¼ 168) aged 40–80 years previously diagnosed with MCI from the Dementia Disease
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Initiation (DDI) cohort and fit regression models to confirm that the norms reliably
adjust for demographic variables when applied to an independent sample.
Methods and materials
The DDI cohort employs a standardized protocol for participant selection and assess-
ment and includes healthy controls, as well as participants with subjective cognitive
decline (SCD) and MCI. Healthy control subjects were recruited primarily from spouses
of symptomatic participants (SCD or MCI), and secondarily from volunteers responding
to advertisements in media, newspapers, or news bulletins. The cohort was recruited
between 2013 and 2018. Criteria for inclusion were age between 40 and 80 years and
a native language of Norwegian, Swedish, or Danish. Exclusion criteria were brain
trauma or disorder, including clinical stroke, dementia, severe psychiatric disorder,
severe somatic disease that might influence cognitive functions, or intellectual disabil-
ity or other developmental disorders. At the time of analysis, 168 fluent Norwegian
speakers, 166 (98.8%) Norwegian native and 2 (1.2%) Swedish native healthy controls
were included (n¼ 168). A subset of these controls (n¼ 23) were missing total sum
scores on the CERAD WLT 20-item recognition subtest (total true positives and true
negatives) due to the scoring of only true positives (10-item score). These subjects
were removed from further analysis, leaving a total of n¼ 145 with total sum scores
on this test. The healthy controls were all able to complete the CERAD WLT in accord-
ance with test instructions (detailed below). In order to evaluate the regression-based
norms in an independent sample, we included 168 fluent Norwegian speakers, 167
(99.4%) native Norwegian and 1 (0.6%) native Danish participants from the DDI cohort
previously diagnosed with MCI. MCI cases from the Trønderbrain cohort was not
included in this analysis since the sample was smaller compared to the MCI sample
from the DDI cohort, and slightly different cognitive tests and diagnostic algorithms
for classification of MCI diagnosis were used (Berge et al., 2016; Fladby et al., 2017). In
the DDI cohort, MCI was determined according to published criteria (Albert et al.,
2011; Petersen, 2004), and cases were classified as cognitively impaired when obtain-
ing a score 1.5 standard deviation below the normative mean on CERAD word list
delayed recall (using norms from Sotaniemi et al. (2012)), Visual Object and Space
Perception Battery (VOSP) silhouettes (Warrington & James, 1991), Trail Making Test B
(TMT-B) or Controlled Oral Word Association test (COWAT) (Heaton, Miller, Taylor, &
Grant, 2004). Cognitive functioning was also assessed by the Clinical Dementia Rating
scale (CDR) (Hughes, Berg, Danziger, Coben, & Martin, 1982). Participants with demen-
tia were excluded if CDR was >0.5 (Petersen, 2004). For further description of the DDI
cohort and methods, see Fladby et al. (2017).
The Trønderbrain cohort recruited participants with MCI, early AD dementia and
healthy controls between 2009 and 2015. Healthy controls were recruited from soci-
eties for retired people in central Norway, or spouses of recruited MCI or early AD
dementia participants. At the time of analysis, 59 healthy controls with Norwegian
native language aged 57–80 years were included. They were all able to complete the
CERAD WLT in accordance with test instructions (detailed below). The CERAD recogni-
tion subtest was not administered and normative data for this subtest is therefore
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only available from the DDI cohort. Exclusion criteria were a present psychiatric or
malignant disease (i.e. currently undergoing treatment for cancer), use of anticoagu-
lant medication, or high alcohol consumption. For further description of the
Trønderbrain cohort and methods, see Berge et al. (2016). An outline of the participant
inclusion process is depicted in Figure 1.
Participants were recruited and assessed from several university hospitals across
Norway. This covered a representative sample of residents in cities and nearby rural
areas from northern Norway (Troms and Finnmark, n¼ 10), mid-Norway (n¼ 66,
Trondheim), south-east Norway (n¼ 58, Akershus/Oslo), south-west Norway (n¼ 43,
Bergen and n¼ 50, Stavanger/Haugesund).
CERAD word list test version and administration
The CERAD WLT was translated to Norwegian by Liv Barnett in 2004 using the 10-item
word list from the original CERAD test description. The Norwegian version was sourced
from CERAD (Gerda Fillenbaum, PhD) at the Center for the Study of Aging and Human
Development, USA (Fillenbaum et al., 2008). The following words (and Norwegian
translation) were used: Queen (Dronning), Grass (Gress), Arm (Arm), Cabin (Hytte), Pole
(Stokk), Shore (kyst), Butter (Smør), Engine (Motor), Ticket (Billett), Letter (Brev). The
test was administered by healthcare professionals (medical doctors, nurses and psy-
chologists) at the different sites. Beforehand, all had received training in the adminis-
tration of the CERAD WLT by the DDI projects senior/chief neuropsychologist, prof.
Erik Hessen.
Figure 1. Flowchart depicting an outline of the participant inclusion process from the Trønderbrain
and DDI cohorts and workflow of the paper.
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The CERAD WLT learning score was obtained from the sum of three 10-word learn-
ing trials yielding a maximum score of 30. After 10min, participants were asked to
recall the words from the 10-word learning trials, yielding a maximum score of 10. We
did not record intrusions or perseverations. Finally, a recognition trial comprising 20
words was administered where 10 of the words were distractors, and 10 words were
target items from the 10-word learning list. This yielded a maximum score of 20 (10
true positive and 10 true negative responses). However, total sum of false positives
was not recorded for the present project.
The following procedure was used when administering the CERAD WLT (here trans-
lated from Norwegian to English):
CERAD WLT trial 1
Verbal instruction to participant: “I will now show you 10 words consecutively. Read
every word out loud. Afterward I will ask you to recall the presented words”
Instruction to the test administrator: Show every word for 2 s, if the participant is
not able to read the word, please read the word out loud for the participant.
CERAD WLT trial 2–3
Verbal instruction to participant: “I will now show you 10 words consecutively once
more. Read every word out loud. Afterward I will ask you to recall the pre-
sented words”
Instruction to the test administrator: Same as for trial 1 instruction detailed above.
CERAD WLT Recall trial (presented 10min after trial 3 administration)
Verbal instruction to participant: “A little while ago, I asked you to learn and remem-
ber a list of words, which you read out loud for me one at a time. Now, I want you to
recall as many of those 10 words as you can remember”.
CERAD WLT Recognition trial
Verbal instruction to participant: “Now I will read out loud all 10 words from the list in
addition to some other words that were not on the list. I want you to reply “Yes” if
you recognize a word from the list you read out loud for me, and “No”, if it is a word
that did not belong to the list you read out loud”.
Statistical analysis
Multiple linear regression analyses with age, gender and years of education as predic-
tors were fitted to model CERAD WLT performance in healthy controls (n¼ 227).
Models were also fitted with interaction terms (age squared) to test for non-linear rela-
tionships between age and test performance (i.e. improving with younger age, and
declining with older age). However, the inclusion of this interaction term did not add
to the overall explained variance (adjusted R2) of the regression models. Thus, only lin-
ear terms were included in our models. Overall estimates of the models (adjusted R2,
F value, p value), and relative contributions for individual predictors (b, partial R2,
p value) are reported. Since the DDI and Trønderbrain cohorts employ slightly different
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criteria for inclusion and exclusion, this variable was assessed in separate regression
models to assess a potential between-cohort bias. However, no significant bias of
cohort was found.
Norming procedure
Due to a marked ceiling effect, the CERAD recognition subtest failed to produce a nor-
mal distribution of test scores, which is required for the regression-based norming pro-
cedure. Our data suggest that age and gender are the strongest demographic
contributors to test performance. Thus, percentiles split by gender are provided for
non-geriatric (e.g. 40–64 years, n¼ 85) and geriatric (65–80 years, n¼ 60) groups
(Table 1).
As shown in Figure 1, the CERAD learning and recall raw test scores from the
healthy control group were used to develop demographically adjusted regression-
based norms. Methods and rationale used for regression-based norming in this paper
are similar to procedures employed by Heaton et al. (2004), Testa, Winicki, Pearlson,
Gordon, and Schretlen (2009) and Parmenter, Testa, Schretlen, Weinstock-Guttman,
and Benedict (2010). We first normalized the control groups raw test scores by retriev-
ing the cumulative frequency distribution of both measures. The resulting distribution
was converted into a standard scaled score with a mean of 10, and a standard devi-
ation of 3 (Table 2). We regressed the resulting scaled scores on age, gender and edu-
cation. Plots of standardized residuals predicted values were assessed to ensure that
the assumption of homoscedasticity was not violated, and normality of the residuals
was checked visually with Q-Q plots. To derive normative information and calculate
demographically adjusted T scores for each participant in the MCI group, we used the
multiple regression equations derived from this analysis (Table 3) to compute the par-
ticipants predicted scaled scores. The participants scaled score, derived from the
healthy control group’s normal distribution (Table 2) was subtracted from the regres-
sion equation predicted scaled score for each participant. The resulting discrepancy
score was divided by the standard deviation of healthy control group’s residuals
(Table 3) to yield a standardized z score, which was then converted to a T score.
Lastly, multiple linear regression analyses with age, gender and years of education
as predictors were fitted to the DDI MCI group’s CERAD WLT learning and recall T
Table 1. Cumulative percentiles for the CERAD WLT recognition subtest.
Non-geriatric (64 years) Geriatric (65 years)
Male n¼ 33 Female n¼ 52 Total n¼ 85 Male n¼ 26 Female n¼ 34 Total n¼ 60
Age range
(mean)
45–64 (57.8) 40–64 (54.8) 40–64 (55.9) 65–80 (70.4) 65–78 (69.6) 65–80 (69.9)
Mean (SD) 19.2 (1.1) 19.8 (0.6) 19.6 (0.9) 19.0 (1.7) 19.2 (1.2) 19.1 (1.4)
Range 16.0–20.0 17.0–20.0 16.0–20.0 13.0–20.0 15.0–20.0 13.0–20.0
2% 16 17 17 13 15 13
5% 17 19 17 14 17 15
10% 17 19 19 16 18 17
25% 19 20 19 19 19 19
50% 20 20 20 20 20 20
75% 20 20 20 20 20 20
90% 20 20 20 20 20 20
Notes. n: Number of participants; SD: standard deviation.
6 B.-E. KIRSEBOM ET AL.
score distributions to confirm adequate adjustment of demographic variables in an
independent sample. All analyses were performed in the Statistical Package for Social
Sciences (SPSS) version 25.
Norm calculator implementation
To facilitate the adoption and usage of the proposed norms in the clinic, we have
developed a norm calculating tool that computes the regression equations. The func-
tionality is simple and straightforward. To obtain both learning and recall T Scores, the
user needs to enter valid demographic (age, gender and years of education) values
and respective raw scores obtained from the tests. The tool is implemented as a self-
contained HTML/Javascript webpage, available at (https://uit.no/ressurs/uit/cerad/
cerad-calc.html), and released as open source at https://bitbucket.org/apgem/cerad-
calc under Apache License, version 2.0.
Ethics
Both DDI and the Trønderbrain projects had been approved by the regional medical
research ethics committees. Before taking part in the study, participants gave their
written informed consent. All further study conduct was in line with the guidelines
Table 2. Raw score to scaled score conversions.
















Table 3. Normative regression models for CERAD WLT Learning and Recall subtests.
Variable Predictor B Standard error B T SD residual
CERAD Word list Learning
Constant 14.195 1.600 8.871 2.54678
Age 0.100 0.020 5.024
Gender 1.060 0.354 2.992
Education 0.113 0.053 2.125
CERAD Word list Recall
Constant 13.756 1.571 8.759 2.51947
Age 0.093 0.020 4.752
Gender 1.176 0.350 3.359
Education 0.107 0.052 2.045
Notes. B: unstandardized regression coefficient; T: the t test statistic; SD: standard deviation.
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provided by the Helsinki declaration of 1964 (revised 2013) and the Norwegian Health
and Research Act.
Results
Demographic characteristics in healthy controls compared to the MCI group
The demographic characteristics of the healthy control group (n¼ 227) are summar-
ized in Table 4 and compared to pertinent demographics of the independent MCI
sample (n¼ 168) using summary independent t tests. While the MCI group obtained
significantly lower raw scores in both CERAD WLT learning (p< .0001) and recall subt-
ests (p< .0001), the groups were similar with regards to mean age and years
of education.
Impact of demographics on the CERAD WLT performance within the healthy
control group
Multiple regression analysis showed advancing age to predict decline in performance
(b¼.310, partial R2¼ .101, p< .0001), whereas years of education (b¼ .126, partial
R2=.018, p< .05) and female gender (b¼ .201, partial R2=.046, p< .001) was associated
with increased performance on the CERAD word list learning subtest (adjusted
R2=.164, F (3,223¼ 15.751, p< .0001). Similarly, younger age (b¼.279, partial
R2¼ .083, p< .0001), higher education (b¼ .139, partial R2¼ .022, p< .05) and female
gender (b¼ .208, partial R2¼ .048, p<.01) predicted better performance on the CERAD
word list recall subtest (adjusted R2¼ .151, F (3,224)¼ 14.418, p< .0001). No collinear-
ity was observed between the predictor variables in any of the models (Variance
Inflation Factor <1.1).
Regression-based norms and scoring instruction
Table 3 shows the regression models based on the healthy controls to derive norms
for the CERAD learning and recall subtests. All models include coefficients to adjust
for age, gender (male¼ 0, female¼ 1) and years of education.
Table 4. Demographics, raw scores and T scores of the healthy controls and MCI group.
Healthy controls n¼ 227 MCI group n¼ 168
Variables Test scores/demographics Test scores/demographics Sig.
Age 63.1 (8.6) [40–80] 64.4 (9.4) [40–80] n.s
Gender (% females) 62 54
Years of education 14.2 (3.2) [7–23] 13.6 (3.4) [7–22] n.s
CERAD WORD LIST (30) LEARNING
Raw score 21.5 (3.3) 16.9 (4.3) p< .0001*
T score 50.0 (10.0) 38.7 (10.1) p< .0001*
CERAD WORD LIST (10) RECALL
Raw score 7.2 (2.0) 4.3 (2.7) p< .0001*
T score 50.0 (10.0) 37.4 (11.4) p< .0001*
Notes. n: Number of participants; MCI: mild cognitive impairment; Sig.: significance tests; p: p value; T: T score; n.s.:
non-significant result. Results are presented as mean (standard deviation) [range] except for gender which is charac-
terized by female percentage. Summary independent T tests. Significant p values are shown in bold.
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The raw test scores of the MCI group (n¼ 168) were converted to T scores using
the following stepwise procedure: (1) Look up the scaled score for a given subtest in
Table 2. (2) Use the regression coefficients found in Table 3 to obtain a predicted
scaled score [constantþ individual age(coefficient for age)þindividual gender(coeffi-
cient for gender)þindividual years of education(coefficient for education)]. (3) Then,
subtract the actual scaled score from the predicted scaled score and divide it by the
standard deviation of the residual (Table 3) to obtain a standardized z score which
may be converted to a T score [T¼ z(10)þ50]. For example, the T score calculation for
a 50-year-old male with 8 years of education with a scaled score of 10 (Table 2) on
CERAD learning: 14.195þ 50(0.100)þ8(0.113)þ0(1.060)=10.099. The difference
between actual (10) and the predicted scaled score (10.099) is 0.099. Divided by the
standard deviation of the healthy control groups residuals (2.54678) gives a z score of
0.039 which equates to a T score of 49.61.
Evaluation of demographic adjustment in the MCI group
Multiple regression models with age, gender and years of education as predictors
were non-significant in the MCI group for both regression derived normative CERAD
learning T scores (adjusted R2=.009, F (3,165¼ 1.531, p=.208) and CERAD recall T scores
(adjusted R2=.005, F (3,165¼ 1.293, p=.279), indicating adequate adjustment of pertin-
ent demographics when norms are applied to an independent sample.
Discussion
In this study, we have developed demographically adjusted norms for the CERAD WLT
aimed at ages 40–80 years in a Norwegian sample. To our knowledge, this is the first
normative study offering CERAD WLT norms aimed at this age interval, adjusted for the
effects of both age, gender and education. As expected, increasing age had the largest
impact on CERAD word list performance, followed by smaller effects of education and
gender. These findings are in line with previous studies showing declining performance
with increasing age (Sotaniemi et al., 2012; Welsh et al., 1994), a positive effect of educa-
tional attainment on performance (Beeri et al., 2006) and a female advantage on tests
of verbal list learning tests or vocabulary (Beeri et al., 2006; Heaton et al., 2004; Liu
et al., 2011). Thus, the regression-based norms were developed adjusted for these
demographics. Healthy controls were recruited from two different prospective
Norwegian cohorts. No between-cohort bias on test performance was found.
Regression-based norming procedures require stringent methodological criteria to
be met (Testa et al., 2009). However, when criteria are met, this method has several
advantages over the conventional discrete norming approach. Since we are using the
entire normative sample, regression norming allows for the adjustment of several
covariates in a linear fashion, meaning that the estimation of normative performance
is possible at yearly increases in age and education for both males and females.
Moreover, this is achieved with a lower sample size than required by discrete norms
(Oosterhuis et al., 2016). However, when assumptions of linear regression are violated
(i.e. normal distribution of errors, homoscedasticity and linearity), this method may
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produce biased and unreliable estimates (Oosterhuis et al., 2016). In this study, efforts
were made to ensure that assumptions of homoscedasticity and normal distributions
of residuals were met. Furthermore, age is non-linearly related to many cognitive func-
tions, including memory performance, with increasing capacity in early life superseded
by a slow decline in later life (Hartshorne & Germine, 2015). We accounted for non-
linearity by introducing an age squared term in our regression models. However,
non-linearity was not demonstrated in our data, possibly because learning and mem-
ory capacity is fully developed, or showing normal age-related decline in this age
cohort (Hartshorne & Germine, 2015).
While the normative data provided by Hankee et al. (2016) provide age adjusted nor-
mative data for younger ages (primarily for ages 35–55years), comparisons with the pro-
posed regression-based norms would not be appropriate due to the insufficient
coverage of older ages (40–80years). Similarly, the norms by Sotaniemi et al. (2012) ori-
ginally employed in the DDI study are based on an older cohort with lower educational
level compared to the participants enrolled in the DDI study (Kirsebom et al., 2017).
In summary, this prompted the need to provide adequate norms covering ages for both
earlier, and later stages of disease development and progression. We therefore opted to
assess normative performance in an independent sample of MCI cases drawn from the
DDI study covering both younger and older patients. We found that the regression-
based norms successfully adjusted for age, gender and years of education in an inde-
pendent sample of MCI cases. Furthermore, estimated T scores in the MCI group
reflected an impaired normative performance with mean scores below 1 SD compared
to the healthy controls. Owing to the successful adjustment of pertinent demographics,
impaired learning and memory recall on the CERAD WLT should therefore be due to
factors largely independent of normal aging, gender differences and educational level.
Interestingly, while years of education did predict higher performance on both
CERAD WLT learning and recall subtests, the explained variance was relatively low
(about 2%) compared to gender (about 5%). The relatively low variance explained by
this variable may be due to a high mean educational level in both the healthy control
group (14.2 years) and in the independent MCI group (13.6 years). While these mean lev-
els seem fairly high, they are consistent with Norwegian population statistics (Statistics
Norway, 2018), which indicate that 37.4% of Norwegians have completed upper second-
ary school (12–13 years) and 33.4% of the population has obtained a university degree
(bachelor’s degree or higher) with more than 15years of education in total. As such, the
relatively high educational level observed in our study could be a cultural bias, which
could influence estimated normative performance on neuropsychological tests (Hayden
et al., 2014; Heaton et al., 2004). These norms were developed in a Norwegian sample.
However, they should be adequate for other Scandinavian countries which share similar-
ities in culture, education and language. While all of our healthy controls were fluent in
Norwegian, two participants (0.9%) were Swedish natives, who had lived in Norway
most of their adult lives. Similarly, one Norwegian speaking Danish native (0.4%) was
included in the MCI sample. The English CERAD WLT items were translated to
Norwegian using back translation procedure to ensure accuracy.
A noteworthy finding using the predictions offered from the regression norms is
that younger people between the ages of 40–50, and especially women, generally do
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very well on this test, and the estimated normative performance for these individuals
is therefore truncated and skewed. This indicates that the CERAD WLT may be too
easy for these individuals. Thus, in order to detect longitudinal change in cognitive
proficiency due to degenerative brain disease, we recommend the addition of a more
challenging wordlist test such as the Rey Auditory Verbal Learning Test (RAVLT)
(Schmidt, 1996) for younger individuals.
A limitation of this study is the missing scores on the CERAD WLT recognition
memory test. In addition, this subtest shows a marked ceiling effect, and does not pro-
duce a normal distribution of test scores required for regression-based norming. Our
data indicate that age and gender had the highest influence on normative perform-
ance. Thus, normative performance on this test is shown by providing cumulative per-
centile ranks for geriatric (65) and non-geriatric (64) age groups, further split by
gender. Secondly, we did not have a complete longitudinal record of our healthy con-
trols to verify that they remained cognitively healthy within a reasonable timeframe.
Thirdly, while the regression equations will mathematically estimate age, and
educational effects beyond the age and education range in this study, estimates are
not reliable beyond these ranges. Finally, regression-based norms may not be as easy
and familiar to use for clinicians compared to conventional discrete norms. In order to
overcome this, we offer a free web-based intuitive normative calculator (supplemen-
tary file 1/https://uit.no/ressurs/uit/cerad/cerad-calc.html).
Conclusion
We propose demographically adjusted regression-based norms for the CERAD WLT,
based on healthy controls from the Norwegian DDI and Trønderbrain cohorts. The
norms are linearly adjusted for the effects of gender, age and education between the
ages of 40 and 80 years, with an educational attainment between 7 and 23 years.
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